Page 6 - Patrick Wingrove News Today

U.S. drug regulators in September found quality control lapses at Moderna’s main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine, according to the report...

U.S. drug regulators in September found quality control lapses at Moderna’s main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine, according to the report obtained by Reuters via a Freedom of Information Act request. The Sept. 11-21 inspection by the U.S. Food and Drug Administration took place at Moderna’s facility in Norwood, Massachusetts, which is used to manufacture the company’s COVID shot Spikevax and an experimental mRNA c...

By Patrick Wingrove (Reuters) - U.S. drug regulators in September found quality control lapses at Moderna’s main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine, according to the report obtained by Reut...

By Michael Erman and Patrick Wingrove (Reuters) -An experimental messenger RNA cancer vaccine developed by Moderna and Merck & Co paired with Mercks ...

U.S. employers facing surging costs from paying for Novo Nordisk’s Wegovy and similar obesity drugs are hiring virtual healthcare providers like Teladoc to implement weight-loss management programs, a dozen consultants, pharmacy benefit managers, analysts, and providers told Reuters. These programs may require diet and exercise before granting access to the medicines, and in some cases will become employees' sole covered option for medications like Wegovy and Eli Lilly’s riva...

U.S. employers facing surging costs from paying for Novo Nordisk’s Wegovy and similar obesity drugs are hiring virtual healthcare providers like Teladoc to implement...

The Biden Administration has announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.

By Patrick Wingrove (Reuters) - The Biden Administration on Thursday announced it is setting new policy that will allow it to seize patents for medici...

By Patrick Wingrove (Reuters) -The Biden Administration on Thursday announced it is setting new policy that will allow it to seize patents for medicines ...

The company has narrowed its focus on its drugs and medical devices business since it hived off its consumer health unit earlier this year. "We think we're very well positioned, even in spite of what will be the beginning of some biosimilar entrants to Stelara outside the US in mid to second half of 2024," Chief Financial Officer Joseph Wolk told Reuters. J&J, which plans to launch at least 20 new therapies by 2030, said over 10 of its products had the potential to generate...